ArticleChemMedChem2017

Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer.

Ulrich Lücking et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.